A Spatially Controlled Glioblastoma‐on‐a‐Chip for Dissecting Tumor‐Immune‐Vascular Crosstalk and Bevacizumab Resistance
- DOI
- 10.1002/adhm.71711
- Published
- 2026-09-09
- Container
- Advanced Healthcare Materials
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/adhm.71711,
title = {A Spatially Controlled Glioblastoma‐on‐a‐Chip for Dissecting Tumor‐Immune‐Vascular Crosstalk and Bevacizumab Resistance},
author = {Zixuan Wang and Jie Gao and Junned Chan and Yongcong Fang and Yanmei Zhang and Xin Liu and Jingjing Xia and Heyun Mao and Yuxin Miao and Zhouyuan Ji and Yueming Tian and Jin Gu and Ting Zhang and Dongsheng Kong and Zhuo Xiong},
year = {2026},
journal = {Advanced Healthcare Materials},
doi = {10.1002/adhm.71711},
url = {https://doi.org/10.1002/adhm.71711}
}RIS
TY - JOUR TI - A Spatially Controlled Glioblastoma‐on‐a‐Chip for Dissecting Tumor‐Immune‐Vascular Crosstalk and Bevacizumab Resistance AU - Zixuan Wang AU - Jie Gao AU - Junned Chan AU - Yongcong Fang AU - Yanmei Zhang AU - Xin Liu AU - Jingjing Xia AU - Heyun Mao AU - Yuxin Miao AU - Zhouyuan Ji AU - Yueming Tian AU - Jin Gu AU - Ting Zhang AU - Dongsheng Kong AU - Zhuo Xiong PY - 2026 JO - Advanced Healthcare Materials DO - 10.1002/adhm.71711 UR - https://doi.org/10.1002/adhm.71711 ER -
APA
Wang, Z., Gao, J., Chan, J., Fang, Y., Zhang, Y., Liu, X., Xia, J., Mao, H., Miao, Y., Ji, Z., Tian, Y., Gu, J., Zhang, T., Kong, D., & Xiong, Z. (2026). A Spatially Controlled Glioblastoma‐on‐a‐Chip for Dissecting Tumor‐Immune‐Vascular Crosstalk and Bevacizumab Resistance. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71711
Source records
- crossref · retrieved 2026-09-25T02:32:07.993Z